 |
A weekly print online publication - marketing engine: interviews and news - publicly
traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX, OTC: BB,
Pink Sheets), Canadian (TSX & TSX-V) and International stock exchanges. |
CEOCFO-Members
Login |
|
Provectus
Pharmaceuticals Executes
Purchase Agreements for
Approximately $5.3
Million Private
Placement - March
9, 2010
Dr. Sanjiv Agarwala to
Present Update on
Provectus' PV-10 -
March 8, 2010
Beacon Enterprise
Solutions Announces Two
New Engagements with
Consumer Companies -
March 8, 2010
Vical to Present at
Upcoming Investor
Conferences - March 1,
2010
California United Bank
Announces Positive
Fourth Quarter
Performance and Strong
2009 Results - February
28, 2010
Fifth Street Finance
Corp. Promotes Bernard
D. Berman to President
and Announces New Board
Member - February 25,
2010
Fifth Street Finance
Corp. Receives Long Term
Financing Commitment of
Up to $150 Million -
February 25, 2010
Brandywine Realty Trust
Announces Fourth Quarter
and Full Year 2009
Earnings - February 24,
2010
Publication of Vical's
H5N1 Results Paves the
Way for H1N1 Clinical
Trial - February 24,
2010
AMERICAN NATIONAL
BANKSHARES INC. (VA)
ANNOUNCES SHELF
REGISTRATION - February
19, 2010
AMERICAN NATIONAL
BANKSHARES INC. (VA)
ANNOUNCES FIRST QUARTER
2010 CASH DIVIDEND -
February 17, 2010
Vical Reports 2009
Financial Results and
Progress in Key
Development Programs -
February 11, 2010
Fifth Street Finance
Corp. Announces Quarter
Ended December 31, 2009
Financial Results -
February 9, 2010
Brandywine Realty Trust
Executes 641,433 Square
Feet of Leasing in
Fourth Quarter 2009 -
February 8, 2010
More
|
Current Issue
All rights reserved - ceocfointerviews.com
Walter Banks, Publisher,
Christy Rivers, Editor-In-Chief, Charlie Diaz, Associate Publisher & Marketing
Director, Lynn
Fosse, Senior Editor, Margaret M. Arraiz, Editor, Mike
Ponikiewicz, Director of Production and website Publishing.
To view Interviews: highlight &
left click on the company name!
March 12,
2010
Healthcare, Technology & Resources
Healthcare
Drug Manufacturers - Major
Provectus Pharmaceuticals, Inc.
(PVCT-OTC: BB)
We have solved the essential problem that other scientists and companies
have not been able to solve; that is to make a cancer specific drug. We have
found out how to make it simply, pragmatically and inexpensively; namely, to
build it and make a very safe molecule. - Dr. H. Craig Dees, Ph.D.
Subscribe-Now!!!
Subscriber Reviews
All rights reserved - ceocfointerviews.com
Healthcare
Biotechnology
Urigen Pharmaceuticals, Inc.
(URGP-OTC: BB)
Actually, the last pharmaceutical innovation for Painful Bladder
Syndrome/Interstitial Cystitis was innovated by our scientific founder,
which is important to the Urigen story. He developed a drug, which now sells
about $175 million that is marketed in the US by a division of Johnson &
Johnson, and co-promoted by Bayer Corporation as well. However, it was
approved in late 1996. So since then in those thirteen or fourteen years we
haven’t had a new innovation, and that is the standard of care. With that
drug, you have to take it three times per day generally for six months, and
you can imagine waiting for six months for a response to your pain, which
may not come. So that gives you an idea of the opportunity for URG101, which
actually works in a matter of minutes during an office visit. So it is truly
a paradigm-shifting product potentially and that is what I saw meeting
patients in Dr. Parsons’ clinic in 2003 at the University of California San
Diego. - Dr. William J. Garner M.D.
Technology
Liquid Phase Desposition
Natcore Technology Inc. (NXT-TSXV)
Precisely what we are doing with the technology is we replacing the vacuum
harnesses, which put on the antireflective coating. Every solar cell has to
have an anti-reflective coating. Right now it is done by putting in vacuum
harnesses at very high temperatures. Our technology puts the same
antireflective coating on those particular solar cells at room temperature
in a liquid bath. - Charles Provini
Resources
Precious Metals
A25 Gold Producers Corp. (ALQ-Frankfurt)
There are not many gold mines where you are going to get concentrations of
up to 310 grams per tonne; that is 9 ounces per tonne. So if you are
extracting 9 ounces per tonne and gold is getting close to $1,500 an ounce,
that is a lot of money. - Jim Adams
|
No part of this publication may be reproduced in any form,
photocopied or retransmitted or stored in a retrieval system without prior written consent
publisher of CEOCFOinterviews.com
Contents of this publication are
gathered from sources believed to be reliable, but are not warranted by
ceocfointerview.com for any particular use or purpose.
CEOCFOinterviews.com does not purchase stock, and the content of this publication
may change and may not be deemed as investment advice.
Any company
publishing an analyst interview to accompany their CEO interview has paid considerations
to CEOCFOinterviews.com. To support the
independence of an analyst interview, CEOCFOinterviews.com does not submit analyst
interviews for review or editing prior to publication, but CEOCFOinterviews.com can not
ensure the independence of the analyst. The
Analyst Industry Review was not paid for by any company being published and is strictly
editorial.
|